Ontology highlight
ABSTRACT:
SUBMITTER: Joseph RW
PROVIDER: S-EPMC7561540 | biostudies-literature | 2020 Oct
REPOSITORIES: biostudies-literature
Joseph Richard W RW Liu Frank Xiaoqing FX Shillington Alicia C AC Macahilig Cynthia P CP Diede Scott J SJ Dave Vaidehi V Harshaw Qing Q Saretsky Todd L TL Pickard Alan Simon AS
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 20200513 10
<h4>Background</h4>Pembrolizumab (PEMBRO) and ipilimumab + nivolumab (IPI + NIVO) are approved advanced melanoma (AM) immunotherapies. To address limited health-related quality of life (QoL) real-world evidence with immunotherapies in AM, we compared QoL in AM patients receiving either treatment in clinical practice.<h4>Methods</h4>A prospective US observational study enrolled adult AM patients initiating first-line PEMBRO or IPI + NIVO between June 2017 and March 2018. Endpoints included the QL ...[more]